SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGPBiotechnology
+$0.45 today
- Market cap
- $993.14M
- Beta
- -0.34
- P/E (TTM)
- -14.1
- EPS (TTM)
- -$1.32
Volume 0.10M
Average 0.09M
SGP Total Current Assets
All assets expected to be converted to cash or used up within one year.
SpyGlass Pharma, Inc. Common StockNASDAQ: SGP
Total Current Assets · Q1 FY2026 · quarter ended Mar 2026
Total current assets of $253.36M in Q1 FY2026
Q1 FY2026 total current assets was $253.36M.
Context
- Total current assets amounted to 98.1% of total assets at the end of Q1 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Assets history
USD · from the balance sheet
- Latest · FY2025
- 108.77M USD
- Year-over-year change
- —
| Period | Period end | Total Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 108.77M | — |
Total Current Assets vs competitors
How SGP compares with its peers on the latest reported figures
- Peers report in different currencies, so total current assets is compared through growth and share of total assets rather than absolute size.
- Total current assets amounts to 98.1% of total assets for SGP, versus a peer median of 86.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $6.97B USD | +10.2% | +7.5% | 22.2% | |
| Jun 2026 | $2.92B USD | +2.7% | +11.7% | 21.1% | |
| Mar 2026 | $706M USD | +82.1% | +82.1% | 96.4% | |
| Jun 2026 | $515.78M USD | +18.3% | +2.3% | 56.0% | |
| Apr 2026 | $312.4M USD | -4.3% | -0.0% | 69.2% | |
| Mar 2026 | $279.23M USD | -3.2% | +28.8% | 91.9% | |
SGPSpyGlass Pharma, Inc. Common Stock | Mar 2026 | $253.36M USD | — | — | 98.1% |
| Mar 2026 | $249.5M USD | -23.7% | +23.9% | 86.6% | |
| Mar 2026 | CHF 226.36M CHF | +19.9% | +110.0% | 93.1% | |
| Mar 2026 | $106.51M USD | -16.1% | -18.7% | 97.1% | |
| Peer median (excluding SGP) | — | +2.7% | +11.7% | 86.6% | |
Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGP
Intrinsic Alpha fair value
Locked
Current Price
$29.68
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.